SCHEMBL8239154

SCHEMBL8239154

O=C(CCc1ccccc1)NCCCNc1nccc(-c2ccc(Cl)cc2Cl)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.46
LMNA P02545 3/20 0.46
ALDH1A1 P00352 1/20 0.46
PIK3CA P42336 4/20 0.45
PIK3CB P42338 4/20 0.45
PIK3CG P48736 4/20 0.45
TBK1 Q9UHD2 1/20 0.43
AKT3 Q9Y243 1/20 0.43
HPGD P15428 2/20 0.42
JAK2 O60674 1/20 0.42
CCNT1 O60563 1/20 0.41
CCNA2 P20248 1/20 0.41
CDK2 P24941 1/20 0.41
CDK9 P50750 1/20 0.41
KDM4E B2RXH2 1/20 0.41
PLAAT3 P53816 1/20 0.41
PLAAT5 Q96KN8 1/20 0.41
PLAAT2 Q9NWW9 1/20 0.41
PLAAT4 Q9UL19 1/20 0.41
MAPT P10636 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4380274 0.85 PIK3CA (0.53) PIK3CAPIK3CBPIK3CGAKT3JAK2
SCHEMBL4583186 0.84 PIK3CA (0.44) L3MBTL1LMNAPIK3CAPIK3CBPIK3CG
SCHEMBL8230866 0.82 PIK3CA (0.47) PIK3CAPIK3CBPIK3CGAKT3JAK2
SCHEMBL4385243 0.81 JAK2 (0.63) PIK3CAPIK3CBPIK3CGAKT3JAK2
SCHEMBL13588448 0.80 PIK3CA (0.52) PIK3CAPIK3CBPIK3CGAKT3JAK2
SCHEMBL4387875 0.80 PIK3CA (0.46) ALDH1A1PIK3CAPIK3CBPIK3CGAKT3
SCHEMBL13588449 0.77 PIK3CA (0.47) PIK3CAPIK3CBPIK3CGAKT3JAK2
SCHEMBL5093415 0.72 PIK3CA (0.55) ALDH1A1PIK3CAPIK3CBPIK3CGCCNT1
SCHEMBL5000363 0.70 AKT3 (0.78) AKT3
SCHEMBL5006003 0.67 AKT3 (0.79) AKT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007089768-A2 4-ARYL-2-AMINO-PYRIMIDINES OR 4-ARYL-2-AMINOALKYL-PYRIMIDINES AS JAK-2 MODULATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM EXELIXIS, INC. (US) 2007-08-09 WO disclosed